Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (1)

2023

  1. PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk

    International Journal of Molecular Sciences, Vol. 24, Núm. 3